BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16595163)

  • 1. Gene expression and association analysis of LIM (PDLIM5) in major depression.
    Iga J; Ueno S; Yamauchi K; Numata S; Motoki I; Tayoshi S; Kinouchi S; Ohta K; Song H; Morita K; Rokutan K; Tanabe H; Sano A; Ohmori T
    Neurosci Lett; 2006 Jun; 400(3):203-7. PubMed ID: 16595163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder.
    Iga J; Ueno S; Yamauchi K; Numata S; Tayoshi-Shibuya S; Kinouchi S; Nakataki M; Song H; Hokoishi K; Tanabe H; Sano A; Ohmori T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):658-63. PubMed ID: 17257729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia.
    Kato T; Iwayama Y; Kakiuchi C; Iwamoto K; Yamada K; Minabe Y; Nakamura K; Mori N; Fujii K; Nanko S; Yoshikawa T
    Mol Psychiatry; 2005 Nov; 10(11):1045-55. PubMed ID: 16044170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
    Wakabayashi Y; Uchida S; Funato H; Matsubara T; Watanuki T; Otsuki K; Fujimoto M; Nishida A; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1199-205. PubMed ID: 18430502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of glyoxalase-1 mRNA in mood disorder patients.
    Fujimoto M; Uchida S; Watanuki T; Wakabayashi Y; Otsuki K; Matsubara T; Suetsugi M; Funato H; Watanabe Y
    Neurosci Lett; 2008 Jun; 438(2):196-9. PubMed ID: 18455873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders.
    Su TP; Zhang L; Chung MY; Chen YS; Bi YM; Chou YH; Barker JL; Barrett JE; Maric D; Li XX; Li H; Webster MJ; Benedek D; Carlton JR; Ursano R
    J Psychiatr Res; 2009 Sep; 43(13):1078-85. PubMed ID: 19380152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression.
    Belzeaux R; Formisano-Tréziny C; Loundou A; Boyer L; Gabert J; Samuelian JC; Féron F; Naudin J; Ibrahim EC
    J Psychiatr Res; 2010 Dec; 44(16):1205-13. PubMed ID: 20471034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major single nucleotide polymorphism of the PDLIM5 gene associated with recurrent major depressive disorder.
    Liu Z; Liu W; Xiao Z; Wang G; Yin S; Zhu F; Wang H; Cheng J; Wang X; He X; Li W
    J Psychiatry Neurosci; 2008 Jan; 33(1):43-6. PubMed ID: 18197271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosducin-like protein levels in leukocytes of patients with major depression and in rat cortex: the effect of chronic treatment with antidepressants.
    Matuzany-Ruban A; Schreiber G; Farkash P; Avissar S
    Psychiatry Res; 2006 Mar; 141(3):287-94. PubMed ID: 16510194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
    Hsiao CC
    Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis.
    Ehde DM; Kraft GH; Chwastiak L; Sullivan MD; Gibbons LE; Bombardier CH; Wadhwani R
    Gen Hosp Psychiatry; 2008; 30(1):40-8. PubMed ID: 18164939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.
    Mihaljevic Peles A; Bozina N; Sagud M; Rojnic Kuzman M; Lovric M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1439-44. PubMed ID: 18550244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.
    Lin KM; Tsou HH; Tsai IJ; Hsiao MC; Hsiao CF; Liu CY; Shen WW; Tang HS; Fang CK; Wu CS; Lu SC; Kuo HW; Liu SC; Chan HW; Hsu YT; Tian JN; Liu YL
    Pharmacogenomics; 2010 Nov; 11(11):1535-43. PubMed ID: 21121774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular assessment of depression from mRNAs in the peripheral leukocytes.
    Iga J; Ueno S; Ohmori T
    Ann Med; 2008; 40(5):336-42. PubMed ID: 18484345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.
    Giusti L; Mantua V; Da Valle Y; Ciregia F; Ventroni T; Orsolini G; Donadio E; Giannaccini G; Mauri M; Cassano GB; Lucacchini A
    Mol Biosyst; 2014 Jun; 10(6):1246-54. PubMed ID: 24554194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese population.
    Nakataki M; Iga J; Numata S; Yoshimoto E; Kodera K; Watanabe SY; Song H; Ueno S; Ohmori T
    Neurosci Lett; 2011 Feb; 489(2):126-30. PubMed ID: 21146590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum markers support disease-specific glial pathology in major depression.
    Schroeter ML; Abdul-Khaliq H; Krebs M; Diefenbacher A; Blasig IE
    J Affect Disord; 2008 Dec; 111(2-3):271-80. PubMed ID: 18430474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response.
    Tzang RF; Hong CJ; Liou YJ; Yu YW; Chen TJ; Tsai SJ
    Neurosci Lett; 2008 Dec; 447(1):92-5. PubMed ID: 18838110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered sirtuin deacetylase gene expression in patients with a mood disorder.
    Abe N; Uchida S; Otsuki K; Hobara T; Yamagata H; Higuchi F; Shibata T; Watanabe Y
    J Psychiatr Res; 2011 Aug; 45(8):1106-12. PubMed ID: 21349544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.